Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Capital Leases (2016 - 2021)

Pharma-Bio Serv filings provide 11 years of Capital Leases readings, the most recent being $52430.0 for Q1 2021.

  • On a quarterly basis, Capital Leases fell 18.37% to $52430.0 in Q1 2021 year-over-year; TTM through Jan 2021 was $52430.0, a 18.37% decrease, with the full-year FY2020 number at $55439.0, down 17.35% from a year prior.
  • Capital Leases hit $52430.0 in Q1 2021 for Pharma-Bio Serv, down from $55439.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $72668.0 in Q2 2019 to a low of $20206.0 in Q2 2017.
  • Median Capital Leases over the past 5 years was $56397.0 (2018), compared with a mean of $53923.1.
  • Biggest five-year swings in Capital Leases: surged 162.12% in 2018 and later fell 24.61% in 2019.
  • Pharma-Bio Serv's Capital Leases stood at $59795.0 in 2017, then fell by 23.03% to $46027.0 in 2018, then surged by 45.74% to $67079.0 in 2019, then dropped by 17.35% to $55439.0 in 2020, then decreased by 5.43% to $52430.0 in 2021.
  • The last three reported values for Capital Leases were $52430.0 (Q1 2021), $55439.0 (Q4 2020), and $58408.0 (Q3 2020) per Business Quant data.